This article has been corrected to remove a reference to Affymetrix's CytoScan HD product, which was incorrectly identified as Agilent's product.
By Tony Fong
NEW YORK (GenomeWeb News) – Will Agilent Technologies become the next big player in the diagnostics space?
Probably not, according to one Wall Street analyst.